why choose us

First received: September 12, 2022

Clinical Trial: Vancomycin Study in Multiple Sclerosis (MS)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Sclerosis

Study Type: INTERVENTIONAL


Official Title: Impact of Vancomycin on the Gut Microbiome and Immune Function in Multiple Sclerosis

Brief Summary: The overall goal of this study is to elucidate a mechanism by which vancomycin modulates the gut-brain axis in multiple sclerosis (MS).The gut microbiome plays an important role in autoimmunity, including MS.However, the identity of gut microbes modulating neuroinflammation in MS and their mechanisms of action remain obscure.Hence, here the research team proposes to investigate the effects of vancomycin on the gut microbiota composition, peripheral immune function, and brain MRI lesions in MS patients.

Read more